456 related articles for article (PubMed ID: 25781442)
1. Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants.
Nan H; Hutter CM; Lin Y; Jacobs EJ; Ulrich CM; White E; Baron JA; Berndt SI; Brenner H; Butterbach K; Caan BJ; Campbell PT; Carlson CS; Casey G; Chang-Claude J; Chanock SJ; Cotterchio M; Duggan D; Figueiredo JC; Fuchs CS; Giovannucci EL; Gong J; Haile RW; Harrison TA; Hayes RB; Hoffmeister M; Hopper JL; Hudson TJ; Jenkins MA; Jiao S; Lindor NM; Lemire M; Le Marchand L; Newcomb PA; Ogino S; Pflugeisen BM; Potter JD; Qu C; Rosse SA; Rudolph A; Schoen RE; Schumacher FR; Seminara D; Slattery ML; Thibodeau SN; Thomas F; Thornquist M; Warnick GS; Zanke BW; Gauderman WJ; Peters U; Hsu L; Chan AT; ;
JAMA; 2015 Mar; 313(11):1133-42. PubMed ID: 25781442
[TBL] [Abstract][Full Text] [Related]
2. Interaction between polymorphisms in aspirin metabolic pathways, regular aspirin use and colorectal cancer risk: A case-control study in unselected white European populations.
Sheth H; Northwood E; Ulrich CM; Scherer D; Elliott F; Barrett JH; Forman D; Wolf CR; Smith G; Jackson MS; Santibanez-Koref M; Haile R; Casey G; Jenkins M; Win AK; Hopper JL; Marchand LL; Lindor NM; Thibodeau SN; Potter JD; Burn J; Bishop DT
PLoS One; 2018; 13(2):e0192223. PubMed ID: 29425227
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of nonsteroidal anti-inflammatory drugs on colorectal adenomas is modified by a polymorphism in peroxisome proliferator-activated receptor delta.
Siezen CL; Tijhuis MJ; Kram NR; van Soest EM; de Jong DJ; Fodde R; van Kranen HJ; Kampman E
Pharmacogenet Genomics; 2006 Jan; 16(1):43-50. PubMed ID: 16344721
[TBL] [Abstract][Full Text] [Related]
4. Aspirin, NSAIDs, and colorectal cancer: possible involvement in an insulin-related pathway.
Slattery ML; Samowitz W; Hoffman M; Ma KN; Levin TR; Neuhausen S
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):538-45. PubMed ID: 15066917
[TBL] [Abstract][Full Text] [Related]
5. Systematic review: interactions between aspirin, and other nonsteroidal anti-inflammatory drugs, and polymorphisms in relation to colorectal cancer.
Andersen V; Vogel U
Aliment Pharmacol Ther; 2014 Jul; 40(2):147-59. PubMed ID: 24889212
[TBL] [Abstract][Full Text] [Related]
6. Exploratory Genome-Wide Interaction Analysis of Nonsteroidal Anti-inflammatory Drugs and Predicted Gene Expression on Colorectal Cancer Risk.
Wang X; Su YR; Petersen PS; Bien S; Schmit SL; Drew DA; Albanes D; Berndt SI; Brenner H; Campbell PT; Casey G; Chang-Claude J; Gallinger SJ; Gruber SB; Haile RW; Harrison TA; Hoffmeister M; Jacobs EJ; Jenkins MA; Joshi AD; Li L; Lin Y; Lindor NM; Marchand LL; Martin V; Milne R; Maclnnis R; Moreno V; Nan H; Newcomb PA; Potter JD; Rennert G; Rennert H; Slattery ML; Thibodeau SN; Weinstein SJ; Woods MO; Chan AT; White E; Hsu L; Peters U
Cancer Epidemiol Biomarkers Prev; 2020 Sep; 29(9):1800-1808. PubMed ID: 32651213
[TBL] [Abstract][Full Text] [Related]
7. Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer.
Peleg II; Maibach HT; Brown SH; Wilcox CM
Arch Intern Med; 1994 Feb; 154(4):394-9. PubMed ID: 8117171
[TBL] [Abstract][Full Text] [Related]
8. The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland.
Macarthur M; Sharp L; Hold GL; Little J; El-Omar EM
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1613-8. PubMed ID: 16030091
[TBL] [Abstract][Full Text] [Related]
9. Association of Aspirin and Nonsteroidal Anti-Inflammatory Drugs With Colorectal Cancer Risk by Molecular Subtypes.
Amitay EL; Carr PR; Jansen L; Walter V; Roth W; Herpel E; Kloor M; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M
J Natl Cancer Inst; 2019 May; 111(5):475-483. PubMed ID: 30388256
[TBL] [Abstract][Full Text] [Related]
10. Aspirin and NSAID chemoprevention, gene-environment interactions, and risk of colorectal cancer.
Wender RC
JAMA; 2015 Mar; 313(11):1111-2. PubMed ID: 25781439
[No Abstract] [Full Text] [Related]
11. Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women.
Reeves MJ; Newcomb PA; Trentham-Dietz A; Storer BE; Remington PL
Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):955-60. PubMed ID: 8959316
[TBL] [Abstract][Full Text] [Related]
12. Synergism interaction between genetic polymorphisms in drug metabolizing enzymes and NSAIDs on upper gastrointestinal haemorrhage: a multicenter case-control study.
Mallah N; Zapata-Cachafeiro M; Aguirre C; Ibarra-García E; Palacios-Zabalza I; Macías-García F; Piñeiro-Lamas M; Ibáñez L; Vidal X; Vendrell L; Martin-Arias L; Sáinz-Gil M; Velasco-González V; Bacariza-Cortiñas M; Salgado A; Estany-Gestal A; Figueiras A;
Ann Med; 2022 Dec; 54(1):379-392. PubMed ID: 35114859
[TBL] [Abstract][Full Text] [Related]
13. Variants downstream of the ornithine decarboxylase gene influence risk of colorectal adenoma and aspirin chemoprevention.
Barry EL; Mott LA; Sandler RS; Ahnen DJ; Baron JA
Cancer Prev Res (Phila); 2011 Dec; 4(12):2072-82. PubMed ID: 21930798
[TBL] [Abstract][Full Text] [Related]
14. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.
Chan AT; Giovannucci EL; Meyerhardt JA; Schernhammer ES; Curhan GC; Fuchs CS
JAMA; 2005 Aug; 294(8):914-23. PubMed ID: 16118381
[TBL] [Abstract][Full Text] [Related]
15. Aspirin use, 8q24 single nucleotide polymorphism rs6983267, and colorectal cancer according to CTNNB1 alterations.
Nan H; Morikawa T; Suuriniemi M; Imamura Y; Werner L; Kuchiba A; Yamauchi M; Hunter DJ; Kraft P; Giovannucci EL; Fuchs CS; Ogino S; Freedman ML; Chan AT
J Natl Cancer Inst; 2013 Dec; 105(24):1852-61. PubMed ID: 24317174
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of gene-environment interactions for colorectal cancer susceptibility loci using case-only and case-control designs.
Song N; Lee J; Cho S; Kim J; Oh JH; Shin A
BMC Cancer; 2019 Dec; 19(1):1231. PubMed ID: 31849324
[TBL] [Abstract][Full Text] [Related]
17. PPARgamma and colon and rectal cancer: associations with specific tumor mutations, aspirin, ibuprofen and insulin-related genes (United States).
Slattery ML; Curtin K; Wolff R; Ma KN; Sweeney C; Murtaugh M; Potter JD; Levin TR; Samowitz W
Cancer Causes Control; 2006 Apr; 17(3):239-49. PubMed ID: 16489531
[TBL] [Abstract][Full Text] [Related]
18. Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: colon cancer family registry.
Scherer D; Koepl LM; Poole EM; Balavarca Y; Xiao L; Baron JA; Hsu L; Coghill AE; Campbell PT; Kleinstein SE; Figueiredo JC; Lampe JW; Buck K; Potter JD; Kulmacz RJ; Jenkins MA; Hopper JL; Win AK; Newcomb PA; Ulrich CM; Makar KW
Genes Chromosomes Cancer; 2014 Jul; 53(7):568-78. PubMed ID: 24677636
[TBL] [Abstract][Full Text] [Related]
19. Influence of Smoking, Body Mass Index, and Other Factors on the Preventive Effect of Nonsteroidal Anti-Inflammatory Drugs on Colorectal Cancer Risk.
Wang X; Chan AT; Slattery ML; Chang-Claude J; Potter JD; Gallinger S; Caan B; Lampe JW; Newcomb PA; Zubair N; Hsu L; Schoen RE; Hoffmeister M; Brenner H; Le Marchand L; Peters U; White E
Cancer Res; 2018 Aug; 78(16):4790-4799. PubMed ID: 29921691
[TBL] [Abstract][Full Text] [Related]
20. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
Sandler RS
Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
